Market Outlook of Ophthalmic Ultrasound Devices
The that global sales of Ophthalmic Ultrasound Devices Market in 2021 was held at US$ 432.2 Mn. With 9.0%, the projected market growth during 2022 – 2032 is expected to be significantly higher than the historical growth.
A-Scan is expected to be the highest revenue generating segment, accounting for an expected CAGR rate of 9.1% during 2022 – 2032.
For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7247
Market Segments Covered in Ophthalmic Ultrasound Devices Market Analysis
By Product Type
- Ultrasound Bio Microscope
By End Use
- Ambulatory Surgery Centers
- Ophthalmology Clinics
- North America
- Latin America
The leading players are focusing on growth strategies, such as innovations in the existing product, frequent product launches, and mergers& acquisitions. Some of the recent developments of key Ophthalmic Ultrasound Devices providers are as follows:
- In March 2019, Quantal medical received U.S. FDA approval for the launch of its product called ABSolu.
- In April 2019, Lantheus announced in April that it would combine its microbubble technology with Cerevast’s ocular ultrasound device for the treatment of retinal vascular occlusion. This could be an entryway for newer RVO technologies in the years ahead, which may increase the effective use of recently developed ophthalmic ultrasound systems. Cerevast’s investigational ocular ultrasound program is undergoing a Phase 2b clinical trial in the second quarter of 2019.
Similarly, recent developments related to companies offering Ophthalmic Ultrasound Devices have been tracked by the team at Fact.MR, which are available in the full report.